Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

OptimizeRx Q2 Adj. EPS $0.24 Beats $0.02 Estimate, Sales $29.195M Beat $22.264M Estimate

Author: Benzinga Newsdesk | August 07, 2025 03:02pm
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.02 by 1311.76 percent. This is a 1100 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $29.195 million which beat the analyst consensus estimate of $22.264 million by 31.13 percent. This is a 55.19 percent increase over sales of $18.812 million the same period last year.

Posted In: OPRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist